Philips
Respironics

Imagine relying on a machine to breathe,
only to find out it could be harming you.

For millions living with sleep apnea and respiratory failure, CPAP, BiPAP and ventilators are lifelines. Batch Assessment checks the records behind a device against each requirement, and shows the evidence behind every answer.

Book a demo→ Explore Batch Assessment

But for Philips Respironics,
that lifeline became a public safety crisis.

From complaints to recall.

Every step below is on the public record, and every frame is from the film above.

  1. An FDA inspection document recording that no formal investigation, risk analysis or CAPA was opened in response to at least 175,000 complaints potentially related to degraded foam.

    Since 2008

    Complaints

    An FDA keyword search of consumer complaints since 2008 returned more than 222,000 containing terms such as foam, debris or particles. No formal investigation was opened before 2018.

  2. A whiteboard headed Black Polyurethane Foam Breakdown, showing high heat plus high humidity causing the foam to degrade.

    August 24, 2018

    The email

    An internal Philips Respironics email states that testing confirmed the polyurethane foam used to reduce device noise breaks down under high heat and humidity. The company opens no formal corrective action at the time and keeps its Trilogy ventilator design.

  3. A close-up looking down a human airway.

    By January 2020

    Formaldehyde

    Philips test reports show a DreamStation CPAP device exceeded tolerable formaldehyde limits during initial operation. About a year later, further testing finds that degraded foam could damage DNA and was potentially toxic to cells.

  4. A diagram of the FDA recall classes, with Class I marked as most serious.

    June 2021

    The recall

    Philips begins a voluntary recall the FDA says covers over 15 million devices, later rated Class I, the FDA's most serious level.

  5. An FDA page on medical device reports, with the line about 561 reports of death highlighted.

    By September 2023

    Death reports

    Since April 2021, the FDA has received 561 reports of death reportedly associated with the foam breakdown or suspected foam breakdown.

  6. The words April 2024 over a spread of one hundred dollar bills.

    April 2024

    Settlement

    Philips agrees to a $1.1 billion U.S. injury settlement without admitting fault.

Safe for their intended users, not idealized conditions.

A cloud of white vapour with fine dark particles caught in it, against black.
Philips' risk evaluation Natural defenses could clear it. For its Trilogy ventilators, Philips concluded patients' natural defenses could remove foam particles, and based its risk evaluation on humidifiers or bacterial filters.
An elderly patient asleep in a hospital bed beside a ventilator with red digital readouts.
The FDA's response Fragile patients may not. The FDA said this did not address medically fragile ventilator patients, who may lack healthy lung function to clear such particles.

Both the humidifier and the filter were treated as optional add-on accessories.

What changes with Batch Assessment

Compliance doesn't end when a product reaches the market.

It takes continuous monitoring, timely investigation, and effective corrective action based on real patient risks.

Batch Assessment supports that work. Register the records you already hold, such as complaint logs, test reports and CAPA records, and the AI agent checks them against each requirement in turn. It shows the evidence behind every answer, and the final judgment stays with your experts.

A laboratory microscope in a bright, white lab.

Complaints, tests and corrective actions, checked against each requirement.

What that result looks like for a single requirement, as an illustration.

Fictional example Former QSR, 21 CFR 820.198

Complaint handling

Judgment
  1. Evidenced
  2. Partially evidenced
  3. Not evidenced
  4. Out of scope
Reasoning

Complaints are logged, but no record shows each one was evaluated to decide whether an investigation was needed.

Source
  • Complaint log §3
  • Test report TR-12
  • CAPA register §1
Missing evidence

Investigation decisions for related complaints

Escalation points

Trend: repeated similar complaints with no CAPA opened

Fictional example for illustration only. It is not an assessment of Philips Respironics or its records.

教訓を、
行動に。 Turn lessons
into action.

査察の前に、御社の記録を確かめましょう。Check your own records before an inspection does.

デモを予約Book a demo ユタ・メディカル社の事例を見るThe Utah Medical case